<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pulmo</journal-id><journal-title-group><journal-title xml:lang="ru">Пульмонология</journal-title><trans-title-group xml:lang="en"><trans-title>PULMONOLOGIYA</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0869-0189</issn><issn pub-type="epub">2541-9617</issn><publisher><publisher-name>Scientific and Practical Journal “PULMONOLOGIYA” LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18093/0869-0189-2023-33-6-760-771</article-id><article-id custom-type="elpub" pub-id-type="custom">pulmo-4332</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Постковидный синдром и патология капиллярного ложа по данным видеокапилляроскопии</article-title><trans-title-group xml:lang="en"><trans-title>Post-COVID syndrome and capillary bed abnormalities detected by videocapillaroscopy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3353-0537</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нгуен</surname><given-names>Х.К.</given-names></name><name name-style="western" xml:lang="en"><surname>Nguyen</surname><given-names>H. C.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нгуен Хоанг Кыонг – аспирант кафедры госпитальной терапии педиатрического факультета.</p><p>117997, Москва, ул. Островитянова, 1; тел.: (967) 203-42-77</p></bio><bio xml:lang="en"><p>Hoang Cuong Nguyen - Postgraduate student, Department of Hospital Therapy, Pediatric Faculty.</p><p>Ul. Ostrovityanova 1, Moscow, 117997; tel.: (967) 203-42-77</p></bio><email xlink:type="simple">drcuong@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5070-5450</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чучалин</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Chuchalin</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чучалин Александр Григорьевич – доктор медицинских наук, профессор, академик Российской академии наук, заведующий кафедрой госпитальной терапии педиатрического факультета.</p><p>117997, Москва, ул. Островитянова, 1; тел.: (499) 780-08-50</p></bio><bio xml:lang="en"><p>Alexander G. Chuchalin - Doctor of Medicine, Professor, Academician of Russian Academy of Sciences, Head of Department of Hospital Internal Medicine, Pediatric Faculty.</p><p>Ul. Ostrovityanova 1, Moscow, 117997; tel.: (499) 780-08-50</p></bio><email xlink:type="simple">pulmomoskva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное автономное образовательное учреждение высшего образования «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Autonomous Educational Institution of Higher Education “N.I. Pirogov Russian National Research Medical University” of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>12</day><month>12</month><year>2023</year></pub-date><volume>33</volume><issue>6</issue><fpage>760</fpage><lpage>771</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Нгуен Х.C., Чучалин А.Г., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Нгуен Х., Чучалин А.Г.</copyright-holder><copyright-holder xml:lang="en">Nguyen H.C., Chuchalin A.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.pulmonology.ru/pulm/article/view/4332">https://journal.pulmonology.ru/pulm/article/view/4332</self-uri><abstract><p>Постковидный синдром (ПКС) является актуальной проблемой клинической практики. Одышка – наиболее распространенный среди неврологических и сердечно-сосудистых симптомов, которые указывают на низкую толерантность к физической нагрузке (ТФН) и снижение качества жизни пациентов с ПКС.</p><p>Целью исследования явилось изучение патогенеза одышки и факторов микрососудистого повреждения, выявленного с помощью видеокапилляроскопии (ВКС), для лучшего понимания их связи с общей клинической картиной у пациентов с ПКС.</p><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование включены пациенты с ПКС (n = 60), страдающие одышкой, степень которой оценивалась по результатам 6-минутного шагового теста (6-МШТ). Пациенты были распределены на 2 группы: 1-я – больные, у которых выявлена десатурация; 2-я – лица без нарушения сатурации. Патология капиллярного ложа диагностировалась с помощью ВКС.</p></sec><sec><title>Результаты</title><p>Результаты. При выполнении 6-МШТ пациенты с ПКС проходили в среднем 79,5 % прогнозируемого расстояния. У них также отмечалось снижение показателей пульсоксиметрии. Значительные различия наблюдались у пациентов с десатурацией и без таковой, особенно в отношении пройденной дистанции при выполнении 6-МШТ, показателей пульсоксиметрии и одышки до и после 6-МШТ. У пациентов с десатурацией отмечены более высокие значения соотношения показателей десатурации и дистанции, пройденной при выполнении 6-МШТ (desaturation-distance ratio – DDR), индекса O2-GAP и уровня сердечных усилий (СУ), а также значительное снижение процента перфузируемых капилляров (ППК), средней плотности капилляров (ПК) и заметное повышение доли извилистых и разветвленных капилляров. Выявлена прямая корреляция между ППК и диффузионной способностью легких по монооксиду углерода (DLCO) и коэффициентом переноса монооксида углерода (DLCO / Va), дистанцией, пройденной при выполнении 6-МШТ, и процентом прогнозируемой дистанции, а также обратная корреляция между ППК и СУ. Показана прямая корреляция с долей (%) капиллярного восстановления, пройденной дистанции при выполнении 6-МШТ и прогнозируемой дистанции, а также обратная корреляция – с показателем DDR. Аналогичным образом показана прямая корреляция показателей средней ПК и DLCO / Va, тогда как доля (%) извилистых капилляров обратно коррелировала с DLCO, а доля (%) разветвленных капилляров – с DLCO / Va.</p></sec><sec><title>Заключение</title><p>Заключение. Продемонстрирован многофакторный характер механизмов возникновения одышки у пациентов с ПКС, при этом отмечена важная роль васкулопатии. Непрерывный мониторинг пульсоксиметрии, частоты сердечных сокращений и ВКС являются эффективными методами изучения и оценки состояния у пациентов с ПКС и одышкой.</p></sec></abstract><trans-abstract xml:lang="en"><p>Post-COVID syndrome (PCS) is a pressing problem in clinical practice. Dyspnea, along with neurologic and cardiovascular symptoms, is the most common symptom indicating low exercise capacity (EC) that reduces quality of life. The aim of this study was to investigate shortness of breath and the capillary bed abnormalities detected video capillaroscopy (VCS) in patients with PCS.</p><sec><title>Methods</title><p>Methods. The study included patients with PCS (n = 60) suffering from shortness of breath. Dyspnea was assessed using the 6-minute walk test (6-MWT). The capillary bed abnormality was diagnosed using VCS.</p></sec><sec><title>Results</title><p>Results. Patients with ACL walked an average of 79.5% of the predicted distance in the 6-MWT. They also had a decrease in pulse oximetry readings. The patients were divided into 2 groups: 1st – patients with desaturation, 2nd – patients without desaturation. Significant differences were observed between patients with and without desaturation, especially in the 6-MWT distance, pulse oximetry, and dyspnea before and after the 6-MWT. Patients with desaturation had a higher desaturation-to-distance ratio, a higher O2-GAP index, and higher cardiac effort levels, as well as a significant decrease in the proportion of perfused capillaries (PPC), mean capillary density, and a marked increase in the proportion of tortuous and branched capillaries. There was a direct correlation between PPC and diffusing lung capacity for carbon monoxide (DLCO), and carbon monoxide transfer coefficient (DLCO/Va), distance traveled during the 6-MWT and percentage (%) of predicted distance, inverse correlation between PPC and cardiac effort. There was a direct correlation between the percentage (%) of capillary recovery and 6-MWT distance and the percentage (%) of predicted distance, as well as an inverse correlation with the ratio of desaturation indicators and walking distance. Similarly, there was a direct correlation between mean capillary density and DLCO/Va, while the proportion (%) of tortuous capillaries was inversely correlated with DLCO, and the proportion (%) of branched capillaries was inversely correlated with DLCO/Va.</p></sec><sec><title>Conclusion</title><p>Conclusion. The multifactorial nature of the mechanisms of dyspnea in patients with PCS was demonstrated, with the important role of vasculopathy. Continuous monitoring of pulse oximetry, heart rate and VCS are effective methods to screen and assess the condition of patients with PCS and dyspnea.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>COVID-19</kwd><kwd>постковидный синдром</kwd><kwd>васкулопатия</kwd><kwd>одышка</kwd><kwd>6-минутный шаговый тест</kwd><kwd>видеокапилляроскопия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>post-COVID syndrome</kwd><kwd>vasculopathy</kwd><kwd>dyspnea</kwd><kwd>6-minute walk test</kwd><kwd>videocapillaroscopy</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Авторы заявляют об отсутствии внешнего финансирования при проведении исследования и подготовке публикации. Авторы выражают благодарность ординаторам кафедры госпитальной терапии педиатрического факультета Федерального государственного автономного образовательного учреждения высшего образования «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Министерства здравоохранения Российской Федерации за помощь в вычислении плотности капиллярной сети и подготовке списка литературы</funding-statement><funding-statement xml:lang="en">The authors declare that they did not receive any external funding for the study and preparation of the publication. The authors express their gratitude to the residents of the Department of Hospital Therapy of the Pediatric Faculty of the Federal State Autonomous Educational Institution of Higher Education “N.I.Pirogov Russian National Research Medical University” of the Ministry of Health of the Russian Federation for their assistance in calculating the density of the capillary network and preparing a list of references</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Chen C., Haupert S.R., Zimmermann L. et al. Global prevalence of post-Coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J. Infect. Dis. 2022; 226 (9): 1593–1607. DOI: 10.1093/infdis/jiac136.</mixed-citation><mixed-citation xml:lang="en">Chen C., Haupert S.R., Zimmermann L. et al. Global prevalence of post-Coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J. Infect. Dis. 2022; 226 (9): 1593–1607. DOI: 10.1093/infdis/jiac136.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 [Accessed: July 01, 2023].</mixed-citation><mixed-citation xml:lang="en">World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 [Accessed: July 01, 2023].</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166 (1): 111–117. DOI: 10.1164/ajrccm.166.1.at1102.</mixed-citation><mixed-citation xml:lang="en">ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166 (1): 111–117. DOI: 10.1164/ajrccm.166.1.at1102.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Pimenta S.P., Rocha R.B., Baldi B.G. et al. Desaturation – distance ratio: a new concept for a functional assessment of interstitial lung diseases. Clinics (Sao Paulo). 2010; 65 (9): 841–846. DOI: 10.1590/s1807-59322010000900005.</mixed-citation><mixed-citation xml:lang="en">Pimenta S.P., Rocha R.B., Baldi B.G. et al. Desaturation – distance ratio: a new concept for a functional assessment of interstitial lung diseases. Clinics (Sao Paulo). 2010; 65 (9): 841–846. DOI: 10.1590/s1807-59322010000900005.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ora J., Calzetta L., Pezzuto G. et al. A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD. Respir. Med. 2013; 107 (12): 2014–2021. DOI: 10.1016/j.rmed.2013.10.002.</mixed-citation><mixed-citation xml:lang="en">Ora J., Calzetta L., Pezzuto G. et al. A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD. Respir. Med. 2013; 107 (12): 2014–2021. DOI: 10.1016/j.rmed.2013.10.002.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lachant D., Kennedy E., Derenze B. et al. Cardiac effort to compare clinic and remote 6-minute walk testing in pulmonary arterial hypertension. Chest. 2022; 162 (6): 1340–1348. DOI: 10.1016/j.chest.2022.06.025.</mixed-citation><mixed-citation xml:lang="en">Lachant D., Kennedy E., Derenze B. et al. Cardiac effort to compare clinic and remote 6-minute walk testing in pulmonary arterial hypertension. Chest. 2022; 162 (6): 1340–1348. DOI: 10.1016/j.chest.2022.06.025.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng C., Daskalakis C., Falkner B. Non-invasive assessment of microvascular and endothelial function. J. Vis. Exp. 2013; (71): e50008. DOI: 10.3791/50008.</mixed-citation><mixed-citation xml:lang="en">Cheng C., Daskalakis C., Falkner B. Non-invasive assessment of microvascular and endothelial function. J. Vis. Exp. 2013; (71): e50008. DOI: 10.3791/50008.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Пахтусов Н.Н., Юсупова А.О., Привалова Е.В. и др. Эндотелиальная дисфункция и воспаление у пациентов с ишемической болезнью сердца и необструктивным поражением коронарных артерий. Кардиология. 2021; 61 (1): 52–58. DOI: 10.18087/cardio.2021.1.n1423.</mixed-citation><mixed-citation xml:lang="en">Pahtusov N.N., Jusupova A.O., Privalova E.V. et al. [Endothelial dysfunction and inflammation in patients with non-obstructive coronary arteries]. Kardiologiya. 2021; 61 (1): 52–58. DOI: 10.18087/cardio.2021.1.n1423 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Богатырева Ф.М., Каплунова В.Ю., Кожевникова М.В. и др. Оценка структурного и функционального состояния сосудов у пациентов с гипертрофической кардиомиопатией. Кардиология. 2021; 61 (12): 16–21. DOI: 10.18087/cardio.2021.12.n1718.</mixed-citation><mixed-citation xml:lang="en">Bogatyreva F.M., Kaplunova V.Yu., Kozhevnikova M.V. et al. [Assessment of the structural and functional state of blood vessels in patients with hypertrophic cardiomyopathy]. Kardiologiya. 2021; 61 (12): 16–21. DOI: 10.18087/cardio.2021.12.n1718 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tello B.G., Ramos E., Simeón-Aznar C.P. et al. Pos0256 automated capillary detection and image analysis software in capillaroscopy: capillary.io. Ann. Rheum. Dis. 2021; 80 (Suppl. 1): 350–351. DOI: 10.1136/annrheumdis-2021-eular.4022.</mixed-citation><mixed-citation xml:lang="en">Tello B.G., Ramos E., Simeón-Aznar C.P. et al. Pos0256 automated capillary detection and image analysis software in capillaroscopy: capillary.io. Ann. Rheum. Dis. 2021; 80 (Suppl. 1): 350–351. DOI: 10.1136/annrheumdis-2021-eular.4022.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Smith V., Herrick A.L., Ingegnoli F. et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. Autoimmun. Rev. 2020; 19 (3): 102458. DOI: 10.1016/j.autrev.2020.102458.</mixed-citation><mixed-citation xml:lang="en">Smith V., Herrick A.L., Ingegnoli F. et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. Autoimmun. Rev. 2020; 19 (3): 102458. DOI: 10.1016/j.autrev.2020.102458.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bernardino V., Rodrigues A., Lladó A. et al. The impact of nailfold capillaroscopy in the approach of microcirculation. Vascular Biology. 2019. DOI: 10.5772/intechopen.90525.</mixed-citation><mixed-citation xml:lang="en">Bernardino V., Rodrigues A., Lladó A. et al. The impact of nailfold capillaroscopy in the approach of microcirculation. Vascular Biology. 2019. DOI: 10.5772/intechopen.90525.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Carlucci A., Paneroni M., Carotenuto M. et al. Prevalence of exercise-induced oxygen desaturation after recovery from SARS-CoV-2 pneumonia and use of lung ultrasound to predict need for pulmonary rehabilitation. Pulmonology. 2021: S2531-0437(21)00117-3. DOI: 10.1016/j.pulmoe.2021.05.008.</mixed-citation><mixed-citation xml:lang="en">Carlucci A., Paneroni M., Carotenuto M. et al. Prevalence of exercise-induced oxygen desaturation after recovery from SARS-CoV-2 pneumonia and use of lung ultrasound to predict need for pulmonary rehabilitation. Pulmonology. 2021: S2531-0437(21)00117-3. DOI: 10.1016/j.pulmoe.2021.05.008.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Fernández-de-Las-Peñas C., Palacios-Ceña D., Gómez-Mayordomo V. et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur. J. Intern. Med. 2021; 92: 55–70. DOI: 10.1016/j.ejim.2021.06.009.</mixed-citation><mixed-citation xml:lang="en">Fernández-de-Las-Peñas C., Palacios-Ceña D., Gómez-Mayordomo V. et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur. J. Intern. Med. 2021; 92: 55–70. DOI: 10.1016/j.ejim.2021.06.009.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Daher A., Balfanz P., Cornelissen C. et al. Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae. Respir. Med. 2020; 174: 106197. DOI: 10.1016/j.rmed.2020.106197.</mixed-citation><mixed-citation xml:lang="en">Daher A., Balfanz P., Cornelissen C. et al. Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae. Respir. Med. 2020; 174: 106197. DOI: 10.1016/j.rmed.2020.106197.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lam G.Y., Befus A.D., Damant R.W. et al. Exertional intolerance and dyspnea with preserved lung function: an emerging long COVID phenotype? Respir. Res. 2021; 22 (1): 222. DOI: 10.1186/s12931-021-01814-9.</mixed-citation><mixed-citation xml:lang="en">Lam G.Y., Befus A.D., Damant R.W. et al. Exertional intolerance and dyspnea with preserved lung function: an emerging long COVID phenotype? Respir. Res. 2021; 22 (1): 222. DOI: 10.1186/s12931-021-01814-9.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lee J.H., Yim J.J., Park J. Pulmonary function and chest computed tomography abnormalities 6–12 months after recovery from COVID-19: a systematic review and meta-analysis. Respir. Res. 2022; 23 (1): 233. DOI: 10.1186/s12931-022-02163-x.</mixed-citation><mixed-citation xml:lang="en">Lee J.H., Yim J.J., Park J. Pulmonary function and chest computed tomography abnormalities 6–12 months after recovery from COVID-19: a systematic review and meta-analysis. Respir. Res. 2022; 23 (1): 233. DOI: 10.1186/s12931-022-02163-x.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wen H., Huapaya J.A., Kanth S.M. et al. Quantitative CT metrics associated with variability in the diffusion capacity of the lung of post-COVID-19 patients with minimal residual lung lesions. J. Imaging. 2023; 9 (8): 150. DOI: 10.3390/jimaging9080150.</mixed-citation><mixed-citation xml:lang="en">Wen H., Huapaya J.A., Kanth S.M. et al. Quantitative CT metrics associated with variability in the diffusion capacity of the lung of post-COVID-19 patients with minimal residual lung lesions. J. Imaging. 2023; 9 (8): 150. DOI: 10.3390/jimaging9080150.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Price L.C., Garfield B., Bloom C. et al. Persistent isolated impairment of gas transfer following COVID-19 pneumonitis relates to perfusion defects on dual-energy computed tomography. ERJ Open Res. 2022; 8 (4): 00224. DOI: 10.1183/23120541.00224-2022.</mixed-citation><mixed-citation xml:lang="en">Price L.C., Garfield B., Bloom C. et al. Persistent isolated impairment of gas transfer following COVID-19 pneumonitis relates to perfusion defects on dual-energy computed tomography. ERJ Open Res. 2022; 8 (4): 00224. DOI: 10.1183/23120541.00224-2022.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Grist J.T., Chen M., Collier G.J. et al. Hyperpolarized 129Xe MRI abnormalities in Dyspneic patients 3 months after COVID-19 pneumonia: preliminary results. Radiology. 2021; 301 (1): E353–360. DOI: 10.1148/radiol.2021210033.</mixed-citation><mixed-citation xml:lang="en">Grist J.T., Chen M., Collier G.J. et al. Hyperpolarized 129Xe MRI abnormalities in Dyspneic patients 3 months after COVID-19 pneumonia: preliminary results. Radiology. 2021; 301 (1): E353–360. DOI: 10.1148/radiol.2021210033.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Yu J.Z., Granberg T., Shams R. et al. Lung perfusion disturbances in nonhospitalized post‐COVID with dyspnea – a magnetic resonance imaging feasibility study. J. Intern. Med. 2022; 292 (6): 941–956. DOI: 10.1111/joim.13558.</mixed-citation><mixed-citation xml:lang="en">Yu J.Z., Granberg T., Shams R. et al. Lung perfusion disturbances in nonhospitalized post‐COVID with dyspnea – a magnetic resonance imaging feasibility study. J. Intern. Med. 2022; 292 (6): 941–956. DOI: 10.1111/joim.13558.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou I.Y., Mascia M., Alba G.A. et al. Dynamic contrast-enhanced MRI demonstrates pulmonary microvascular abnormalities months after SARS-CoV-2 infection. Am. J. Respir. Crit. Care Med. 2023; 207 (12): 1636–1639. DOI: 10.1164/rccm.202210-1884LE.</mixed-citation><mixed-citation xml:lang="en">Zhou I.Y., Mascia M., Alba G.A. et al. Dynamic contrast-enhanced MRI demonstrates pulmonary microvascular abnormalities months after SARS-CoV-2 infection. Am. J. Respir. Crit. Care Med. 2023; 207 (12): 1636–1639. DOI: 10.1164/rccm.202210-1884LE.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Østergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol. Rep. 2021; 9 (3): e14726. DOI: 10.14814/phy2.14726.</mixed-citation><mixed-citation xml:lang="en">Østergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol. Rep. 2021; 9 (3): e14726. DOI: 10.14814/phy2.14726.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Mondini L., Confalonieri P., Pozzan R. et al. Microvascular alteration in COVID-19 documented by nailfold capillaroscopy. Diagnostics (Basel). 2023; 13 (11): 1905. DOI: 10.3390/diagnostics13111905.</mixed-citation><mixed-citation xml:lang="en">Mondini L., Confalonieri P., Pozzan R. et al. Microvascular alteration in COVID-19 documented by nailfold capillaroscopy. Diagnostics (Basel). 2023; 13 (11): 1905. DOI: 10.3390/diagnostics13111905.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Natalello G., De Luca G., Gigante L. et al. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvasc. Res. 2021; 133: 104071. DOI: 10.1016/j.mvr.2020.104071.</mixed-citation><mixed-citation xml:lang="en">Natalello G., De Luca G., Gigante L. et al. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvasc. Res. 2021; 133: 104071. DOI: 10.1016/j.mvr.2020.104071.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Hansen-Smith F.M. Capillary network patterning during angiogenesis. Clin. Exp. Pharmacol. Physiol. 2000; 27 (10): 830–835. DOI: 10.1046/j.1440-1681.2000.03341.x.</mixed-citation><mixed-citation xml:lang="en">Hansen-Smith F.M. Capillary network patterning during angiogenesis. Clin. Exp. Pharmacol. Physiol. 2000; 27 (10): 830–835. DOI: 10.1046/j.1440-1681.2000.03341.x.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ackermann M., Verleden S.E., Kuehnel M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N. Engl. J. Med. 2020; 383 (2): 120–128. DOI: 10.1056/NEJMoa2015432.</mixed-citation><mixed-citation xml:lang="en">Ackermann M., Verleden S.E., Kuehnel M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N. Engl. J. Med. 2020; 383 (2): 120–128. DOI: 10.1056/NEJMoa2015432.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Pries A.R., Höpfner M., le Noble F. et al. The shunt problem: control of functional shunting in normal and tumour vasculature. Nat. Rev. Cancer. 2010; 10 (8): 587–593. DOI: 10.1038/nrc2895.</mixed-citation><mixed-citation xml:lang="en">Pries A.R., Höpfner M., le Noble F. et al. The shunt problem: control of functional shunting in normal and tumour vasculature. Nat. Rev. Cancer. 2010; 10 (8): 587–593. DOI: 10.1038/nrc2895.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Baratto C., Caravita S., Faini A. et al. Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study. J. Appl. Physiol. (1985). 2021; 130 (5): 1470–1478. DOI: 10.1152/japplphysiol.00710.2020.</mixed-citation><mixed-citation xml:lang="en">Baratto C., Caravita S., Faini A. et al. Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study. J. Appl. Physiol. (1985). 2021; 130 (5): 1470–1478. DOI: 10.1152/japplphysiol.00710.2020.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Ijiri N., Kanazawa H., Yoshikawa T., Hirata K. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9 (1): 1235–1240. DOI: 10.2147/copd.s71383.</mixed-citation><mixed-citation xml:lang="en">Ijiri N., Kanazawa H., Yoshikawa T., Hirata K. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9 (1): 1235–1240. DOI: 10.2147/copd.s71383.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Ambrosino P., Calcaterra I., Molino A. et al. Persistent endothelial dysfunction in post-acute COVID-19 syndrome: a case-control study. Biomedicines. 2021; 9 (8): 957. DOI: 10.3390/biomedicines9080957.</mixed-citation><mixed-citation xml:lang="en">Ambrosino P., Calcaterra I., Molino A. et al. Persistent endothelial dysfunction in post-acute COVID-19 syndrome: a case-control study. Biomedicines. 2021; 9 (8): 957. DOI: 10.3390/biomedicines9080957.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Willems L., Nagy M., ten Cate H. et al. Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. Thromb. Res. 2022; 209: 106–114. DOI: 10.1016/j.thromres.2021.11.027.</mixed-citation><mixed-citation xml:lang="en">Willems L., Nagy M., ten Cate H. et al. Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. Thromb. Res. 2022; 209: 106–114. DOI: 10.1016/j.thromres.2021.11.027.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">von Meijenfeldt F.A., Havervall S., Adelmeijer J. et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome: comment from von Meijenfeldt et al. J. Thromb. Haemost. 2022; 20 (1): 267–269. DOI: 10.1111/jth.15580.</mixed-citation><mixed-citation xml:lang="en">von Meijenfeldt F.A., Havervall S., Adelmeijer J. et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome: comment from von Meijenfeldt et al. J. Thromb. Haemost. 2022; 20 (1): 267–269. DOI: 10.1111/jth.15580.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Prasannan N., Heightman M., Hillman T. et al. Impaired exercise capacity in post-COVID-19 syndrome: the role of VWF-ADAMTS13 axis. Blood Adv. 2022; 6 (13): 4041–4048. DOI: 10.1182/bloodadvances.2021006944.</mixed-citation><mixed-citation xml:lang="en">Prasannan N., Heightman M., Hillman T. et al. Impaired exercise capacity in post-COVID-19 syndrome: the role of VWF-ADAMTS13 axis. Blood Adv. 2022; 6 (13): 4041–4048. DOI: 10.1182/bloodadvances.2021006944.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
